Article

Lymphocyte Count is a Universal Predictor to the Health Status and Outcomes of Patients with Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Regression Analysis

2021-08-04

Abstract excerpt

Background: This study aimed to evaluate the prediction capabilities of clinical laboratory biomarkers to the prognosis of COVID-19 patients. <br><br>Methods: Observational studies reporting at least 30 cases of COVID-19 describing disease severity or mortality were included. Meta-data of demographics, clinical symptoms, vital signs, comorbidities, and 14 clinical laboratory biomarkers on initial hospital presenta...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b456c332-4430-5d73-bcc9-706e541e3c0a
DOI: 10.2139/ssrn.3899114

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Lymphocyte Count is a Universal Predictor to the Health Status and Outcomes of Patients with Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Regression AnalysisDOI 10.2139/ssrn.3899114Read

Lymphocyte count is a universal predictor to the health status and outcomes of patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-regression analysisSemantic proximity Read

Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.Semantic proximity Read

Platelet-to-lymphocyte ratio (PLR), a novel biomarker to predict the severity of COVID-19 patients: a systematic review and meta-analysisSemantic proximity Read

Implications of Laboratory Tests in Disease Grading and Death Risk-Stratification of COVID-19: A Retrospective Study in Wuhan, ChinaSemantic proximity Read

Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patientsSemantic proximity Read

Potential biomarkers for fatal outcome prognosis in a cohort of hospitalized COVID-19 patients with pre-existing co-morbiditiesSemantic proximity Read

Prognosing the Risk of COVID-19 Death Through a Machine Learning-Based Routine Blood PanelSemantic proximity Read

The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective studySemantic proximity Read

Analysis of Clinical Characteristics of Patients with Critical COVID-19Semantic proximity Read

Reliable and Interpretable Mortality Prediction with Strong Foresight in COVID-19 Patients: An International Study from China and GermanySemantic proximity Read

Complete Blood Count Parameters Can Outperform Regular Inflammatory Markers in Predicting COVID-19 Mortality: A Multimodal Machine Learning ModelSemantic proximity Read

A Prognostic Tool for COVID-19 Decision Support: The Intermountain Risk Score Predicts Major Adverse Health Events in Patients Positive for COVID-19Semantic proximity Read